Table 2.
Cognitive Performance at One Month and One Year in FSE by Demographic Factors
| 1-month | Demographics | Bayley MDI | Bayley PDI | PPVT-3 | McCarthy MI | ||||||||
| N | Mean(Std) | p | N | Mean(Std) | p | N | Mean(Std) | p | N | Mean(Std) | p | ||
| Overall | 151 | 91.97(15.79) | NS** | 158 | 91.18(17.91) | NS | 24 | 77.5(22.16) | NS | 22 | 38.95(10.83) | NS | |
| Gender | Female | 71 | 93.34(16.5) | NS | 75 | 91.84(17.33) | NS | 9 | 73(21.56) | NS | 9 | 37.33(6.98) | NS |
| Male | 80 | 90.75(15.13) | 83 | 90.58(18.49) | 15 | 80.2(22.81) | 13 | 40.08(13.02) | |||||
| Race | Black, Non-Hispanic | 54 | 88.89(16.09)* | 0.044 | 55 | 91.09(20.62) | NS | 7 | 66.43(21.79)* | 0.019 | 8 | 42.5(11.77) | NS |
| White, Non-Hispanic | 53 | 95.00(14.92)* | 56 | 94.32(14.3) | 9 | 91.44(15.94)* | 9 | 40.22(9.65) | |||||
| Hispanic | 36 | 91.44(14.99) | NS | 39 | 87.69(16.71)* | 0.041 | 8 | 71.5(22.42)* | 0.049 | 5 | 31.00(8.92) | NS | |
| White, Non-Hispanic | 53 | 95.00(14.92) | 56 | 94.32(14.3)* | 9 | 91.44(15.94)* | 9 | 40.22(9.65) | |||||
| Not White | 90 | 89.91(15.63) | NS | 94 | 89.68(19.07) | NS | 15 | 69.13(21.49)* | 0.013 | 13 | 38.08(11.88) | NS | |
| White | 53 | 95.00(14.92) | 56 | 94.32(14.3) | 9 | 91.44(15.94)* | 9 | 40.22(9.65) | |||||
| HHV67 | No HHV6/7 Infection | 74 | 90.12(15.49) | NS | 80 | 87.94(17.96)* | 0.048 | 11 | 78.27(16.30) | NS | 10 | 38.80(8.63) | NS |
| HHV6/7 Infection | 45 | 93.29(15.74) | 46 | 94.59(18.08)* | 6 | 74.00(23.68) | 6 | 38.50(10.97) | |||||
| Acute T2 Signal | No Acute T2 Signal | 121 | 91.50(15.40) | NS | 128 | 91.77(17.66) | NS | 18 | 82.06(20.00) | NS | 16 | 40.81(11.67) | NS |
| Acute T2 Signal | 12 | 93.08(16.95) | 12 | 82.33(15.07) | 4 | 68.25(27.78) | 4 | 35.75(6.34) | |||||
| HIMAL | No HIMAL | 125 | 92.13(15.28) | NS | 132 | 91.51(17.79) | NS | 20 | 80.25(22.49) | NS | 19 | 39.79(11.17) | NS |
| HIMAL | 11 | 88.27(16.70) | 11 | 89.55(17.81) | 2 | 72.50(4.95) | 2 | 38.00(2.83) | |||||
| 1-year | Overall | 95 | 87.40(19.38) | NS | 95 | 89.33(19.50) | NS | 56 | 85.54(21.45) | NS | 40 | 42.45(8.24) | NS |
| Gender | female | 45 | 89.76(21.24) | NS | 44 | 90.77(19.88) | NS | 22 | 85.64(23.62) | NS | 16 | 42.38(6.93) | NS |
| male | 50 | 85.28(17.48) | 51 | 88.08(17.32) | 34 | 85.47(20.30) | 24 | 42.50(9.15) | |||||
| Race | Black, Non-Hispanic | 29 | 86.59(17.17) | NS | 27 | 93.11(17.73) | NS | 18 | 79.11(19.43) | NS | 12 | 43.42(8.53) | NS |
| White, Non-Hispanic | 32 | 93.47(13.88) | 31 | 86.68(13.72) | 22 | 91.59(23.13) | 17 | 43.06(8.33) | |||||
| Hispanic | 30 | 81.00(23.71)* | 0.016 | 33 | 88.39(21.88) | NS | 14 | 83.29(20.71) | NS | 9 | 39.22(8.11) | NS | |
| White, Non-Hispanic | 32 | 93.47(13.88)* | 31 | 86.68(13.72) | 22 | 91.59(23.13) | 17 | 43.06(8.33) | |||||
| Not White | 59 | 83.75(20.77)* | 0.009 | 60 | 90.52(20.1) | NS | 32 | 80.94(19.78) | NS | 21 | 41.62(8.42) | NS | |
| White | 32 | 93.47(13.88)* | 31 | 86.68(13.72) | 22 | 91.59(23.13) | 17 | 43.06(8.33) | |||||
| HHV67 | No HHV6/7 Infection | 47 | 88.30(21.77) | NS | 48 | 88.13(21.37) | NS | 29 | 87.76(19.31) | NS | 25 | 40.52(8.01)* | 0.047 |
| HHV6/7 Infection | 26 | 86.42(16.12) | 25 | 92.44(14.03) | 19 | 81.32(23.92) | 10 | 46.70(7.94)* | |||||
| Acute T2 Signal | No Acute T2 Signal | 77 | 88.52(19.15) | NS | 77 | 89.97(18.97) | NS | 47 | 89.87(15.39)* | 0.009 | 36 | 42.31(8.12) | NS |
| Acute T2 Signal | 4 | 82.75(24.16) | 4 | 77.75(15.33) | 5 | 68.00(30.19)* | 1 | 34.00(.) | |||||
| HIMAL | No HIMAL | 79 | 88.73(19.18) | NS | 79 | 89.89(18.66) | NS | 46 | 87.07(20.96) | NS | 30 | 43.20(7.77) | NS |
| HIMAL | 4 | 76.00(21.53) | 4 | 77.50(20.87) | 8 | 85.13(20.29) | 9 | 40.44(10.13) | |||||
*
T-Test Significance Level: <.05; MDI: Mental Development Index; PDI: Psychomotor Development Index; PPVT: Peabody Picture Vocabulary Test; MI: Memory Index
**
NS: Not Significant